Cargando…
Role of PAR2 in regulating oxaliplatin-induced neuropathic pain via TRPA1
Oxaliplatin (OXL) is a third-generation chemotherapeutic agent commonly used to treat metastatic digestive tumors; however, one of the main limiting complications of OXL is neuropathic pain. In this study, the underlying mechanisms responsible for OXL evoked-neuropathic pain were examined. Using a r...
Autores principales: | Tian, Liujun, Fan, Tianren, Zhou, Nan, Guo, Hui, Zhang, Weijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter Open
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936617/ https://www.ncbi.nlm.nih.gov/pubmed/28123794 http://dx.doi.org/10.1515/tnsci-2015-0010 |
Ejemplares similares
-
A TRPA1 antagonist reverts oxaliplatin-induced neuropathic pain
por: Nativi, Cristina, et al.
Publicado: (2013) -
Blocking PAR2 Alleviates Bladder Pain and Hyperactivity via TRPA1 Signal
por: Chen, Daihui, et al.
Publicado: (2016) -
TRPA1 rare variants in chronic neuropathic and nociplastic pain patients
por: Marchi, Margherita, et al.
Publicado: (2023) -
The pain-relieving effects of lactoferrin on oxaliplatin-induced neuropathic pain
por: FUJIMURA, Takeshi, et al.
Publicado: (2020) -
Involvement of Serotonergic System in Oxaliplatin-Induced Neuropathic Pain
por: Lee, Ji Hwan, et al.
Publicado: (2021)